Novartis is looking out for splitting the Drug Business in to two sections. Out of which one section will be looking after Anti-cancaer Drugs while other drugs will be focused by another division
The division shows the growing importance of Oncology section to company.
“Novartis expects this change to help drive our growth and innovation strategy, with an increased focus and improved execution,” the company said in a statement.
For Pharma Jobs: Click here
For Online shopping offers : Click Here